Laboratory of Cancer and Developmental Cell Biology, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA.
Brief Funct Genomics. 2012 Jul;11(4):300-10. doi: 10.1093/bfgp/els022. Epub 2012 Jun 29.
The mitogen-activated protein kinase kinases (the MAPK/ERK kinases; MKKs or MEKs) and their downstream substrates, the extracellular-regulated kinases have been intensively studied for their roles in development and disease. Until recently, it had been assumed any mutation affecting their function would have lethal consequences. However, the identification of MEK1 and MEK2 mutations in developmental syndromes as well as chemotherapy-resistant tumors, and the discovery of genomic variants in MEK1 and MEK2 have led to the realization the extent of genomic variation associated with MEKs is much greater than had been appreciated. In this review, we will discuss these recent advances, relating them to what is currently understood about the structure and function of MEKs, and describe how they change our understanding of the role of MEKs in development and disease.
丝裂原活化蛋白激酶激酶(MAPK/ERK 激酶;MKK 或 MEK)及其下游底物细胞外调节激酶,因其在发育和疾病中的作用而受到广泛研究。直到最近,人们还认为任何影响其功能的突变都会产生致命的后果。然而,MEK1 和 MEK2 突变在发育综合征以及化疗耐药肿瘤中的鉴定,以及 MEK1 和 MEK2 中基因组变异的发现,使得人们意识到与 MEKs 相关的基因组变异程度远远超出了之前的认识。在这篇综述中,我们将讨论这些最新进展,将它们与目前对 MEKs 结构和功能的理解联系起来,并描述它们如何改变我们对 MEKs 在发育和疾病中的作用的理解。